November 5 2020

7:09 pm

Join Us For A Conversation Between Lisa Genova & Greg O’Brien: Dec 1st, 5:30 PM

October 23 2020

VARIATION IN TAU AMONG ALZHEIMER’S PATIENTS MAY EXPLAIN WHY SOME PEOPLE DECLINE AT A FASTER RATE THAN OTHERS

October 23 2020

AMYLYX PHARMACEUTICALS ANNOUNCES COMPLETION OF ENROLLMENT IN THE PEGASUS TRIAL OF AMX0035 IN ALZHEIMER’S DISEASE

October 23 2020

BRAIN IMAGING STUDY SUGGESTS FEMALE-SPECIFIC RISK FACTORS FOR ALZHEIMER’S DISEASE

October 23 2020

FDA Approves First Tau Imaging Agent For PET Scans For Diagnosis of Alzheimer’s Disease

October 23 2020

How Assessing Blood-Brain Barrier Damage in APOE4 Carriers May Predict Cognitive Decline